Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glycosylphosphatidylinositol anchor attachment 1 pseudogene 1 (GPAA1P1) is classified as a pseudogene in the human genome. Pseudogenes are nonfunctional DNA segments resembling coding genes but are generally unable to produce functional RNA or protein products due to accumulated mutations, deletions, or lack of regulatory sequences[2][3]. GPAA1P1 shares homology with the glycosylphosphatidylinositol anchor attachment 1 gene, but does not contribute to cell signaling, metabolic activity, or disease progression. It is not a therapeutic target, not used as a biomarker, and has no reported role in drug response or safety[2][3].
None (no mechanism of action, as it does not encode a therapeutic target[2][3])
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glycosylphosphatidylinositol anchor attachment 1 pseudogene 1 (GPAA1P1).